Scope

Aims and Scope: Integrative Biomedical Research (former Journal of Angiotherapy) is an, international, peer-reviewed, Open Access journal that publishes research articles on all aspects of biomedical, medicine, public health,  disease mechanisms, health Interventions, clinical & translational research, molecular biology, drug delivery, drug discovery, natural sciences, medical research, engineering, biochemistry and integrative biological sciences in a continuous publication schedule.

Additionally, Integrative Biomedical Research (former Journal of Angiotherapy) is committed to advancing scientific understanding of angiogenesis and inflammation as fundamental, interrelated biological processes central to human health, disease, and therapeutic innovation. The journal embraces a broad, integrative biomedical scope, publishing original research, clinical studies, and reviews that explore how vascular biology and inflammatory signaling intersect with pathophysiological mechanisms in diverse disease contexts—including but not limited to metabolic disorders, reproductive dysfunction, oncology, endocrinology, immunology, regenerative medicine, and neurovascular science. JoA particularly welcomes interdisciplinary, translational, and systems-based approaches that elucidate the role of angiogenesis and inflammation in diagnostics, therapeutics, and public health. This includes in silico drug discovery, pharmacological screening, biomarker development, clinical trial outcomes, and health interventions targeting vascular modulation and all domains of pharmacological aspects. Studies investigating indirect or systemic outcomes (e.g., hormonal regulation, tissue growth, translational outcome, integrative biomedical applications or developmental health) are also within scope when such processes are mediated by vascular or inflammatory pathways and any pharmacological relevance.

In alignment with publishing standards practiced by multidisciplinary journals, Integrative Biomedical Research (former Journal of Angiotherapy)  supports a squared-scope model that encourages biologically coherent, application-oriented research—even when the primary disease model or intervention lies outside traditional angiogenesis domains. By doing so, the journal fosters cross-disciplinary insight and contributes meaningfully to integrative biomedical sciences, evidence-based medicine, public-health and integrative applications.

In addition, as a multidisciplinary platform, JoA bridges various fields of biomedical, natural sciences, medical research, engineering and biological sciences, offering a comprehensive exploration of mechanisms and interventions. JoA serves as a dynamic platform for researchers, clinicians, and scientists to explore the complexities of inflammation, diseases, and health interventions.

JoA welcomes the submission of original research articles, reviews, data reports, case studies, clinical trials, and brief communications that present significant, novel findings and advance knowledge within the realm of integartive biomedical research areas.

All accepted manuscripts are published continuously and made freely available online immediately upon publication. This open-access model ensures unrestricted access to research, facilitating widespread dissemination and engagement within the scientific community.

JoA is committed to being a valuable resource for researchers, scientists, and clinicians aiming to expand the boundaries of knowledge in integrative fields.

Peer-Review Process (please see detials in peer review policy and publishing policies)

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single-blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The general criteria for acceptance of a manuscript are:

• advances scientific knowledge;

• advances translational research;

• provides an adequate and relevant literature review;

• utilizes scientifically solid, reliable, and reproducible methodologies;

• derives appropriate and justifiable conclusions based upon the experimental data presented; and

• is written in English and is of the utmost quality and clarity.

Integrative Biomedical Research (former Journal of Angiotherapy) will facilitate the author's response to the NIH Public Access Policy.